| Name | Title | Contact Details |
|---|---|---|
Seth Mitchell |
Director and Head of People and Culture | Profile |
Atritech is a Minneapolis, MN-based company in the Healthcare, Pharmaceuticals, & Biotech sector.
CAMH Centre for Addiction and Mental Health is one of the leading companies in Healthcare, Pharmaceuticals, & Biotech industry. CAMH Centre for Addiction and Mental Health is based in Toronto, ON. You can find more information on CAMH Centre for Addiction and Mental Health at www.camh.net
Riverland Medical Center is one of the leading providers in Healthcare, Pharmaceuticals, & Biotech. It is based in Ferriday, LA. To find more information about Riverland Medical Center, please visit www.riverlandmedical.com
RemedyMD is the leading provider of registries for life sciences. RemedyMDs highly specific patient and disease registry software and comparative effectiveness research tools enable researchers, clinicians and scientists to collect, aggregate, harmonize, and analyze data from widely disparate sources and then use RemedyMD tools and applications to identify patterns that result in accelerated discoveries, better patient outcomes, and advance translational research.
StemCells, Inc., a biopharmaceutical company, engages in the research, development, and commercialization of cell-based therapeutics and tools for use in stem cell-based research and drug discovery primarily in the United States. Its lead therapeutic product candidate, HuCNS-SC cells (purified human neural stem cells), is in development as a potential treatment for a range of central nervous system disorders. The company has conducted a Phase I clinical trial in Pelizaeus-Merzbacher disease, a fatal myelination disorder in children. It is also conducting a Phase I/II clinical trial in chronic spinal cord injury; and has initiated a Phase I/II clinical trial in dry age-related macular degeneration, as well as is pursuing preclinical studies in Alzheimer’s disease. In addition, the company markets a rage of proprietary cell culture products, research grade human cells, and antibody reagents under the SC Proven brand. The proprietary cell culture products include iSTEM, GS1-R, GS2-M, RHB-A, RHB-Basal, NDiff227, NDiff N2, and NDiff N27 supplements, as well as HEScGRO and ESGRO Complete; and antibody reagents comprise STEM24, STEM101, STEM121, and STEM123, which can be used for cell detection, isolation, and characterization. Further, StemCells is involved in developing and commercializing applications of its technologies to enable stem cell-based research. The company sells its tools and technologies products to researchers at academic institutions, pharmaceutical and biotechnology companies, and government laboratories. StemCells, Inc. was founded in 1988 and is headquartered in Newark, California.